The University of Chicago Header Logo

Connection

Ann Marie Mauer to Cetuximab

Back to Details
This is a "connection" page, showing publications Ann Marie Mauer has written about Cetuximab.
Ann Marie Mauer
Connection Strength
0.020
Cetuximab
  1. A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer. Cancer. 2009 Apr 15; 115(8):1713-22.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.